Metabolic
MOTS-c
MOTS-c is a 16-amino-acid mitochondrial-derived peptide often called an "exercise mimetic": it signals between mitochondria and the nucleus to activate AMPK, the master metabolic switch. This increases insulin-independent glucose uptake, promotes fatty-acid oxidation, builds new mitochondria, and improves metabolic flexibility, insulin sensitivity, endurance, and muscle preservation. Circulating levels decline with age and track inversely with insulin resistance. Typically dosed 5–10 mg SubQ, 1–3×/week.
Mechanism
AMPK activation, metabolic flexibility enhancement
Clinical Benefits
Fat oxidation, Training tolerance, Metabolic flexibility
Typical Dose
Cycle Length
Frequency
Synergistic Compounds
5-15 mg
4-8 weeks
2-3x / Week
NAD+, AOD-9604, L-Carnitine, SS-31
At a Glance
Dosage | 5–10 mg subcutaneous, 1–3×/week. |
Protocol | 4–6 weeks on, 2–4 weeks off. Morning dose, ideally 60–90 min before exercise. |
Results timeline | Energy changes within hours; metabolic improvements build over 2–4 weeks; full effects by end of first cycle. |
Side effects | Injection-site burning if reconstituted with plain (hypotonic) BAC water — use isotonic (sodium-chloride) BAC water. |
Regulatory status | Human correlation studies + preclinical. Not FDA-approved (unpatentable). WADA-prohibited since Jan 2025 (S4). |
Best stacked with | NAD+, SS-31 (Mito Stack); GLP-1 agonists (recomposition); L-Carnitine; 5-Amino-1MQ. |
MOTS-c is the closest thing to exercise in a syringe — a peptide encoded in mitochondrial DNA that, on metabolic demand, travels to the nucleus and reprograms gene expression. Circulating levels decline with age and track inversely with insulin resistance. It sits as the metabolic-signaling arm of the Mito Stack (with SS-31 for membrane repair and NAD+ for redox currency), supports GLP-1 protocols against fatigue, and works as a training amplifier 60–90 min pre-exercise. It mimics exercise's metabolic signal but not its mechanical loading — a complement to training, not a replacement.
What MOTS-c Is
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a 16-amino-acid peptide produced by mitochondria — part of a class called mitochondrial-derived peptides (MDPs). On metabolic demand (exercise or caloric restriction), cells release MOTS-c; it travels to the nucleus and changes gene expression so cells preferentially burn fat, spare glycogen, take up glucose without more insulin, and build new mitochondria. This is reprogramming, not stimulation.
How MOTS-c Works
It flips the same switch as exercise (AMPK activation): more mitochondria get built (biogenesis via PGC-1α), glucose handling improves without more insulin (GLUT4 translocation), and cleanup and stress tolerance increase (FOXO activation). The result resembles the metabolic posture of someone who trains consistently.
MOTS-c Benefits
Metabolic flexibility: shifts fuel preference toward fat oxidation and smooths fed/fasted transitions. Insulin sensitivity: insulin-independent glucose uptake; lower MOTS-c correlates with reduced insulin sensitivity in obese adults. Energy/physical capacity: builds mitochondria; late-life treatment in mice (≈70 human years) raised physical capacity and healthspan. Aging/longevity: levels decline with age; Okinawan centenarians carry a functional MOTS-c polymorphism (m.1382A>C).
Profile | Why MOTS-c helps |
Hyperglycemic | Opens alternate glucose-uptake pathway bypassing insulin resistance |
Hypoglycemic | Shifts fuel toward fat, reducing crash frequency |
Low-energy adults | Builds new mitochondria, increases oxidative capacity |
Aging individuals | Restores declining MOTS-c, improves physical capacity |
Athletes | Enhances metabolic adaptation to training |
Dosage and Protocol
SubQ or IM. Reconstitute with isotonic BAC water (with sodium chloride) — plain BAC water causes painful injection reactions. See the reconstitution calculator.
Standard protocol | |
Dose | 5–10 mg (some use 2–5 mg) |
Frequency | 1–3×/week |
Timing | Morning, fasted or 60–90 min before Zone-2 exercise |
Cycle | 4–6 weeks on, 2–4 weeks off |
Practitioner | Dose | Frequency | Duration |
Ben Greenfield | 10 mg | 1×/week | Up to 10 weeks/year |
Dr. William Seeds | 5 mg | 3×/week → 1×/week | 4–6 weeks |
Dr. Rob Kominiarek | 10 mg | 1×/week | 4 weeks |
Jay Campbell | 2–5 mg | Every 3rd day or weekly | Variable |
No consensus — start lower (5 mg). MOTS-c acts over hours, not weeks; morning dosing before cardio aligns with its exercise-mimetic mechanism.
GLP-1 fatigue
GLP-1 agonists shift metabolism rapidly toward fat oxidation, which is more mitochondrially demanding than glucose burning — straining mitochondria already near capacity, producing the "tired but wired" fatigue users report. MOTS-c raises oxidative capacity (AMPK, PGC-1α) so the instruction to burn fat reaches machinery that can execute. Dose 5 mg, 2–3×/week on worst-fatigue mornings; do NOT mix with GLP-1 in the same syringe.
NAD+ synergy
Fat oxidation, the electron transport chain, and sirtuins all consume NAD+. If NAD+ pools are depleted, the MOTS-c signal arrives at a system that can't execute. MOTS-c acts over hours; oral NAD+ precursors take days, so injectable (IV/IM) NAD+ — which peaks within the dosing window — is treated as co-architecture, not optional.
SS-31 priming
Emerging consensus: prime with SS-31 (repairs membrane "hardware") before MOTS-c (activates adaptive "software").
What Users Report
Energy is the primary but variable signal — boosts within ~30 min for responders, crashes for others. MTHFR caution: MOTS-c inhibits the folate cycle (AICAR accumulates, activating AMPK; 5-MTHF and methionine drop), so MTHFR carriers (C677T, A1298C) can crash harder — start 2–3 mg once weekly and pair with methyl donors (methylfolate 400–800 mcg, methyl-B12 1–2 mg, glycine 3 g). Responder phenotype: works best for metabolically compromised, older, sedentary, or GLP-1-fatigued individuals; already-lean biohackers respond less. "Spicy" injection: burning/welts from hypotonic BAC water — fixed with isotonic. Stability and fat-loss claims circulating in forums are unverified single anecdotes.
Side Effects and Safety
Well tolerated in published data. Common: injection-site reactions, mild early fatigue, transient GI discomfort. No serious adverse events in published literature to date. Do NOT mix with GLP-1 agonists in the same syringe (precipitation).
Clinical Research
Study | Population | Finding |
Nat Commun (2021) | Young men | Skeletal-muscle MOTS-c rises ~12-fold after exercise |
Rev Cardiovasc Med (2022) | Elite athletes | Higher baseline MOTS-c and exercise-responsive increases |
J Investig Med (2018) | Obese adults | Lower MOTS-c correlated with reduced insulin sensitivity |
Eur Rev Med Pharmacol Sci (2022) | CAD patients | Lower circulating MOTS-c predicted coronary artery disease |
Diabetes Res Clin Pract (2016) | m.1382A>C carriers | mtDNA variant affecting MOTS-c tracks with metabolic health |
FAQ
What is MOTS-c?
A 16-amino-acid signaling molecule encoded in mitochondrial DNA (a mitochondrial-derived peptide). On metabolic demand, cells release it to coordinate better fuel selection, new mitochondria, and stress tolerance.
What does MOTS-c do?
Activates the same pathways as exercise (primarily AMPK) — shifting metabolism toward fat oxidation, improving insulin-independent glucose uptake, building mitochondria, and increasing stress tolerance.
How long does MOTS-c take to work?
Effects begin within hours; metabolic improvements accumulate over 2–4 weeks; energy/capacity changes within the first 4–6 week cycle.
Can MOTS-c replace exercise?
No — it amplifies exercise's metabolic adaptations but doesn't replace mechanical, neurological, or cardiovascular benefits.
Is MOTS-c safe?
Published human and preclinical data show no significant adverse signals; it's endogenously produced. Long-term data are limited — work with a licensed clinician.
What is the recommended dosage and protocol?
5–10 mg SubQ, 1–3×/week; start at 5 mg. Morning, ideally 60–90 min before Zone-2 cardio. Cycles 4–6 weeks on, 2–4 weeks off (some use once-weekly for up to 10 weeks). Higher doses aren't proportionally better; works best in metabolically compromised individuals.
How do I reconstitute MOTS-c?
Use isotonic BAC water (0.9% sodium chloride) instead of plain BAC water; inject slowly against the vial wall and swirl gently. Plain (hypotonic) BAC water causes painful injection-site reactions.
Why does MOTS-c burn at the injection site?
Hypotonic BAC water causes cell lysis and local irritation. Isotonic BAC water matches tissue osmolality and eliminates the reaction for most users.
Can I take MOTS-c with GLP-1 medications?
Yes — particularly useful against GLP-1 fatigue — but do NOT mix in the same syringe (precipitation). Inject separately; time on worst-fatigue mornings.
Does MOTS-c need to be cycled?
Yes — 4–6 weeks on, 2–4 weeks off preserves responsiveness and mimics endogenous rhythm. Some use once-weekly for longer courses.
What time of day should I take MOTS-c?
Morning, ideally 60–90 min before Zone-2 cardio. A minority who crash dose in the evening instead.
How do I store MOTS-c?
Powder: refrigerate or freeze. Reconstituted: refrigerate 2–8°C, use within 2–4 weeks; protect from light and temperature swings.
Is MOTS-c legal?
Legal to possess/purchase for research in most jurisdictions; not FDA-approved. As of Jan 2025 WADA prohibits it (S4: Hormone and Metabolic Modulators) — athletes should avoid.
Related Topics
NAD+ Guide — essential cofactor for MOTS-c to work
SS-31 Guide — structural repair for mitochondrial membranes
Mitochondrial Stack — MOTS-c + SS-31 + NAD+ combined
Pinealon Guide — circadian and anti-aging overlap
Tesamorelin Guide — GH-axis support for recomposition
BPC-157 Guide — foundational repair peptide
Semaglutide Guide — MOTS-c addresses its energy costs
Tirzepatide Guide — MOTS-c supports during therapy
References
Lee C, et al. MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab 2015. DOI
Reynolds JC, et al. MOTS-c is an exercise-induced regulator of age-dependent physical decline and muscle homeostasis. Nat Commun 2021. DOI
Kim KH, et al. MOTS-c translocates to the nucleus to regulate gene expression under metabolic stress. Cell Metab 2018. DOI
Wan W, et al. MOTS-c: effects and mechanisms related to stress, metabolism and aging. J Transl Med 2023. DOI
Fuku N, et al. MOTS-c: a player in exceptional longevity? Aging Cell 2015. DOI
Mohtashami Z, et al. Folate/methylation context. Biomedicines 2022. DOI
Lee C, Zeng J, et al. MOTS-c: a mitochondrial-encoded peptide that regulates metabolism. Cell Metab 2015. PMID 25738459
Medical Disclaimer
The content in this protocol guide is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before beginning any new protocol, supplement, or medication.